documents: FDA-2020-D-1136-0012

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2020-D-1136-0012 FDA FDA-2020-D-1136 COVID-19 Public Health Emergency_ General Considerations for Pre-IND_Meeting Requests for COVID-19 Related Drugs and Biological Pr-2 Other Guidance 2020-05-13T04:00:00Z 2020 5 2020-05-13T04:00:00Z 2023-05-12T03:59:59Z 2023-05-09T19:20:08Z   0 0 09000064845e8851

Links from other tables